Continuous administration of the three thrombospondin-1 type 1 repeats recombinant protein improves the potency of therapy in an orthotopic human pancreatic cancer model
- 6 June 2006
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 247 (1), 143-149
- https://doi.org/10.1016/j.canlet.2006.04.003
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancerAnnals Of Oncology, 2005
- Antiangiogenic Treatment with the Three Thrombospondin-1 Type 1 Repeats Recombinant Protein in an Orthotopic Human Pancreatic Cancer ModelClinical Cancer Research, 2005
- Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510.2004
- Expression of the Type-1 Repeats of Thrombospondin-1 Inhibits Tumor Growth Through Activation of Transforming Growth Factor-βThe American Journal of Pathology, 2004
- Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane GhostsThe American Journal of Pathology, 2004
- Tumor progression: the effects of thrombospondin-1 and -2The International Journal of Biochemistry & Cell Biology, 2004
- The application of an antiangiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenograftsCancer Gene Therapy, 2000
- Effect of Angiostatin on Liver Metastasis of Pancreatic Cancer in HamstersJapanese Journal of Cancer Research, 2000
- Overexpression of Thrombospondin-1 Decreases Angiogenesis and Inhibits the Growth of Human Cutaneous Squamous Cell CarcinomasThe American Journal of Pathology, 1999
- A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.Proceedings of the National Academy of Sciences, 1990